Terms: = Uterine cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Clinical Outcome
22 results:
1. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
2. Radiomics-based prediction of two-year clinical outcome in locally advanced cervical cancer patients undergoing neoadjuvant chemoradiotherapy.
Autorino R; Gui B; Panza G; Boldrini L; Cusumano D; Russo L; Nardangeli A; Persiani S; Campitelli M; Ferrandina G; Macchia G; Valentini V; Gambacorta MA; Manfredi R
Radiol Med; 2022 May; 127(5):498-506. PubMed ID: 35325372
[TBL] [Abstract] [Full Text] [Related]
3. Impact of PET scanner non-linearity on the estimation of hypoxic fraction in cervical cancer patients.
Gottwald J; Han K; Milosevic M; Yeung I; Jaffray DA
Phys Med; 2022 Jan; 93():1-7. PubMed ID: 34894495
[TBL] [Abstract] [Full Text] [Related]
4. Bioinformatic identification of genomic instability-associated lncRNAs signatures for improving the clinical outcome of cervical cancer by a prognostic model.
Zhang J; Ding N; He Y; Tao C; Liang Z; Xin W; Zhang Q; Wang F
Sci Rep; 2021 Oct; 11(1):20929. PubMed ID: 34686717
[TBL] [Abstract] [Full Text] [Related]
5. HPV transcript expression affects cervical cancer response to chemoradiation.
Ruiz FJ; Inkman M; Rashmi R; Muhammad N; Gabriel N; Miller CA; McLellan MD; Goldstein M; Markovina S; Grigsby PW; Zhang J; Schwarz JK
JCI Insight; 2021 Aug; 6(16):. PubMed ID: 34255749
[TBL] [Abstract] [Full Text] [Related]
6. Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome.
Reijnen C; Küsters-Vandevelde HVN; Ligtenberg MJL; Bulten J; Oosterwegel M; Snijders MPLM; Sweegers S; de Hullu JA; Vos MC; van der Wurff AAM; van Altena AM; Eijkelenboom A; Pijnenborg JMA
Int J Cancer; 2020 Jul; 147(2):478-489. PubMed ID: 32022266
[TBL] [Abstract] [Full Text] [Related]
7. Transcriptomic Characterization of Endometrioid, Clear Cell, and High-Grade Serous Epithelial Ovarian Carcinoma.
Fridley BL; Dai J; Raghavan R; Li Q; Winham SJ; Hou X; Weroha SJ; Wang C; Kalli KR; Cunningham JM; Lawrenson K; Gayther SA; Goode EL
Cancer Epidemiol Biomarkers Prev; 2018 Sep; 27(9):1101-1109. PubMed ID: 29967001
[No Abstract] [Full Text] [Related]
8. Association Between Proportion of Nuclei With High Chromatin Entropy and Prognosis in Gynecological cancers.
Nielsen B; Kleppe A; Hveem TS; Pradhan M; Syvertsen RA; Nesheim JA; Kristensen GB; Trovik J; Kerr DJ; Albregtsen F; Danielsen HE
J Natl Cancer Inst; 2018 Dec; 110(12):1400-1408. PubMed ID: 29684152
[TBL] [Abstract] [Full Text] [Related]
9. Identification and Validation of Reference Genes for RT-qPCR Studies of Hypoxia in Squamous Cervical cancer Patients.
Fjeldbo CS; Aarnes EK; Malinen E; Kristensen GB; Lyng H
PLoS One; 2016; 11(5):e0156259. PubMed ID: 27244197
[TBL] [Abstract] [Full Text] [Related]
10. A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study.
Bender D; Sill MW; Lankes HA; Reyes HD; Darus CJ; Delmore JE; Rotmensch J; Gray HJ; Mannel RS; Schilder JM; Hunter MI; McCourt CK; Samuelson MI; Leslie KK
Gynecol Oncol; 2015 Sep; 138(3):507-12. PubMed ID: 26186911
[TBL] [Abstract] [Full Text] [Related]
11. MicroRNAs in endometrial cancers from black and white patients.
Maxwell GL; Shoji Y; Darcy K; Litzi T; Berchuck A; Hamilton CA; Conrads TP; Risinger JI
Am J Obstet Gynecol; 2015 Feb; 212(2):191.e1-10. PubMed ID: 25174797
[TBL] [Abstract] [Full Text] [Related]
12. Risk assessment tool for distant recurrence after platinum-based concurrent chemoradiation in patients with locally advanced cervical cancer: a Korean gynecologic oncology group study.
Kang S; Nam BH; Park JY; Seo SS; Ryu SY; Kim JW; Kim SC; Park SY; Nam JH
J Clin Oncol; 2012 Jul; 30(19):2369-74. PubMed ID: 22614984
[TBL] [Abstract] [Full Text] [Related]
13. Reporting and validation of gynaecological Groupe Euopeen de Curietherapie European Society for Therapeutic Radiology and Oncology (ESTRO) brachytherapy recommendations for MR image-based dose volume parameters and clinical outcome with high dose-rate brachytherapy in cervical cancers: a single-institution initial experience.
Mahantshetty U; Swamidas J; Khanna N; Engineer R; Merchant NH; Deshpande DD; Shrivastava S
Int J Gynecol Cancer; 2011 Aug; 21(6):1110-6. PubMed ID: 21633296
[TBL] [Abstract] [Full Text] [Related]
14. Intensity-modulated radiotherapy in patients with cervical cancer. An intra-individual comparison of prone and supine positioning.
Stromberger C; Kom Y; Kawgan-Kagan M; Mensing T; Jahn U; Schneider A; Budach V; Köhler C; Marnitz S
Radiat Oncol; 2010 Jul; 5():63. PubMed ID: 20598136
[TBL] [Abstract] [Full Text] [Related]
15. Proteomic profiling of mammary carcinomas identifies C7orf24, a gamma-glutamyl cyclotransferase, as a potential cancer biomarker.
Gromov P; Gromova I; Friis E; Timmermans-Wielenga V; Rank F; Simon R; Sauter G; Moreira JM
J Proteome Res; 2010 Aug; 9(8):3941-53. PubMed ID: 20527979
[TBL] [Abstract] [Full Text] [Related]
16. Gene expression changes in cervical squamous cell carcinoma after initiation of chemoradiation and correlation with clinical outcome.
Klopp AH; Jhingran A; Ramdas L; Story MD; Broadus RR; Lu KH; Eifel PJ; Buchholz TA
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):226-36. PubMed ID: 18406887
[TBL] [Abstract] [Full Text] [Related]
17. Assessing the difference between planned and delivered intensity-modulated radiotherapy dose distributions based on radiobiological measures.
Mavroidis P; Ferreira BC; Papanikotaou N; Svensson R; Kappas C; Lind BK; Brahme A
Clin Oncol (R Coll Radiol); 2006 Sep; 18(7):529-38. PubMed ID: 16969983
[TBL] [Abstract] [Full Text] [Related]
18. HIV infection and invasive cervical cancers, treatment with radiation therapy: toxicity and outcome.
Shrivastava SK; Engineer R; Rajadhyaksha S; Dinshaw KA
Radiother Oncol; 2005 Jan; 74(1):31-5. PubMed ID: 15683666
[TBL] [Abstract] [Full Text] [Related]
19. Reproducibility in double scanning of cervical smears with the PAPNET system.
Doornewaard H; van der Schouw YT; van der Graaf Y
Acta Cytol; 2000; 44(4):604-10. PubMed ID: 10934954
[TBL] [Abstract] [Full Text] [Related]
20. The increment of micronucleus frequency in cervical carcinoma during irradiation in vivo and its prognostic value for tumour radiocurability.
Widel M; Jedruś S; Owczarek S; Konopacka M; Lubecka B; Kołosza Z
Br J Cancer; 1999 Jul; 80(10):1599-607. PubMed ID: 10408406
[TBL] [Abstract] [Full Text] [Related]
[Next]
